Legionellosis (Legionnaires' disease and Pontiac fever)

17 November 2026 | Questions and answers

Legionellosis is the general term for illnesses caused by Legionella bacteria. It has two forms: Legionnaires’ disease, a potentially severe form of pneumonia, and Pontiac fever, a milder influenza-like illness that does not cause pneumonia and is usually self-limiting.

People are most commonly infected by inhaling aerosols containing Legionella produced by contaminated water systems or water-using devices such as evaporative condensers (cooling towers), hot- and cold-water systems, spas and other devices that produce mists or sprays. Aspiration of contaminated water from sources such as chilled water dispensers and ice machines is another possible source, particularly in susceptible hospital patients and in babies exposed during water births. Transmission can also occur from contaminated potting mixes and soils. There is little evidence of person-to-person transmission.

Most people infected by Legionella do not become ill. Most reported cases occur in people over 50 years of age, with males more frequently affected. Factors associated with increased risk include smoking, diabetes, chronic respiratory disease, immunosuppression and excessive alcohol consumption.

Legionnaires’ disease generally develops 2–10 days after exposure. Initial symptoms can include fever, loss of appetite, headache, malaise, dry cough and lethargy. Other symptoms can include muscle pain, nausea, diarrhoea and confusion. Disease can progress to severe pneumonia; common complications include respiratory failure, shock and acute kidney and multi-organ failure.

Pontiac fever generally develops within 5 hours to 3 days and is an acute, milder, non-pneumonic and self-limiting illness with influenza-like symptoms, including fever, headache, nausea, vomiting, muscle and joint pain and coughing.

There is no vaccine currently available for Legionnaire’s disease. Legionnaires’ disease can be treated with antibiotics; Pontiac fever is self-limiting and does not require treatment.

Legionellosis occurs worldwide, but its true incidence is unknown because surveillance, diagnostic capacity and reporting vary substantially between countries. Most reported data come from high-income countries where reported annual incidence rates range from 0.1 to 77 cases per million people. In such settings, it can be the most significant waterborne pathogen.

The public health risk of waterborne legionellosis can be substantially reduced through implementation of device- and building-specific water safety plans. Water safety plans should include control measures targeting conditions that support the growth and survival of Legionella, the presence of biofilms and the production and dissemination of aerosols. These should include avoiding growth temperatures for Legionella (20 oC to 50 oC) and controlling biofilm formation by maintaining disinfectant residuals where practicable, minimizing stagnation and low water flows and regular cleaning.